AIMMUNE THERAPEUTICS INC's ticker is and the CUSIP is 00900T907. A total of 3 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 1,377 | +37.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 1,004 | +224.9% | 0.00% | -100.0% |
| Q1 2020 | $445,000 | -52.3% | 309 | +10.8% | 0.00% | -50.0% |
| Q4 2019 | $933,000 | +94.0% | 279 | +21.3% | 0.00% | +100.0% |
| Q3 2019 | $481,000 | +64.2% | 230 | +63.1% | 0.00% | 0.0% |
| Q2 2019 | $293,000 | +55.0% | 141 | +65.9% | 0.00% | 0.0% |
| Q1 2019 | $189,000 | +44.3% | 85 | +54.5% | 0.00% | – |
| Q4 2018 | $131,000 | -90.2% | 55 | -88.8% | 0.00% | -100.0% |
| Q3 2018 | $1,336,000 | +5.3% | 490 | +3.8% | 0.00% | -20.0% |
| Q2 2018 | $1,269,000 | +42200.0% | 472 | +2147.6% | 0.01% | – |
| Q1 2018 | $3,000 | -88.9% | 21 | -72.0% | 0.00% | -100.0% |
| Q4 2017 | $27,000 | +237.5% | 75 | +476.9% | 0.00% | – |
| Q3 2017 | $8,000 | +60.0% | 13 | -62.9% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 35 | +29.6% | 0.00% | – |
| Q1 2017 | $5,000 | – | 27 | +285.7% | 0.00% | – |
| Q1 2016 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 101,800 | $2,435,000 | 0.00% |
| SIMPLEX TRADING, LLC | 55 | $131,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |